lobbying_filings_raw: dbc99f25-c3f7-4395-ba27-72f5713dfa35
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dbc99f25-c3f7-4395-ba27-72f5713dfa35 | Q4 | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 202836 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2025 | fourth_quarter | 2026-01-17T15:49:45-05:00 | 0 | 0 | 0 | {"url": "https://lda.gov/api/v1/filings/dbc99f25-c3f7-4395-ba27-72f5713dfa35/", "filing_uuid": "dbc99f25-c3f7-4395-ba27-72f5713dfa35", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2025, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.gov/filings/public/filing/dbc99f25-c3f7-4395-ba27-72f5713dfa35/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "70000.00", "expenses_method": "A", "expenses_method_display": "A", "posted_by_name": "Kelly Corredor", "dt_posted": "2026-01-17T15:49:45-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "11400 Rockville Pike", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Rockville", "registrant_state": "MD", "registrant_zip": "20852", "registrant": {"id": 401104864, "url": "https://lda.gov/api/v1/registrants/401104864/", "house_registrant_id": null, "name": "AMERICAN SOCIETY OF ADDICTION MEDICINE", "description": "Medical Professional Society", "address_1": "11400 Rockville Pike", "address_2": null, "address_3": null, "address_4": null, "city": "Rockville", "state": "MD", "state_display": "Maryland", "zip": "20852", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "CAROLYN C. LANHAM", "contact_telephone": "+1 301-547-4104", "dt_updated": "2026-01-13T15:06:19.564018-05:00"}, "client": {"id": 202836, "url": "https://lda.gov/api/v1/clients/202836/", "client_id": 12, "name": "AMERICAN SOCIETY OF ADDICTION MEDICINE", "general_description": "Medical Professional Society", "client_government_entity": false, "client_self_select": true, "state": "MD", "state_display": "Maryland", "country": "US", "country_display": "United States of America", "ppb_state": "MD", "ppb_state_display": "Maryland", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2018-05-01"}, "lobbying_activities": [{"general_issue_code": "ALC", "general_issue_code_display": "Alcohol and Drug Abuse", "description": "Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 68378, "prefix": null, "prefix_display": null, "first_name": "KELLY", "nickname": null, "middle_name": null, "last_name": "CORREDOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 8, "name": "Congressional Budget Office (CBO)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}, {"id": 141, "name": "Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 68378, "prefix": null, "prefix_display": null, "first_name": "KELLY", "nickname": null, "middle_name": null, "last_name": "CORREDOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 8, "name": "Congressional Budget Office (CBO)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}, {"id": 141, "name": "Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 68378, "prefix": null, "prefix_display": null, "first_name": "KELLY", "nickname": null, "middle_name": null, "last_name": "CORREDOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 8, "name": "Congressional Budget Office (CBO)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}, {"id": 141, "name": "Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 68378, "prefix": null, "prefix_display": null, "first_name": "KELLY", "nickname": null, "middle_name": null, "last_name": "CORREDOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 8, "name": "Congressional Budget Office (CBO)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}, {"id": 141, "name": "Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 68378, "prefix": null, "prefix_display": null, "first_name": "KELLY", "nickname": null, "middle_name": null, "last_name": "CORREDOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 8, "name": "Congressional Budget Office (CBO)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}, {"id": 141, "name": "Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}, {"general_issue_code": "INS", "general_issue_code_display": "Insurance", "description": "Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 68378, "prefix": null, "prefix_display": null, "first_name": "KELLY", "nickname": null, "middle_name": null, "last_name": "CORREDOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 8, "name": "Congressional Budget Office (CBO)"}, {"id": 155, "name": "Drug Enforcement Administration (DEA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 137, "name": "Health Resources & Services Administration (HRSA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}, {"id": 141, "name": "Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | MD | US | MD | MD | US | US | Medical Professional Society | 0 | 0 | 70000.0 |